Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPC | P11150 | 1/20 | 0.61 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 7/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | KDM1A | O60341 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | PLK1 | P53350 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CCR2 | P41597 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5114074 | 0.93 | KMT2A (0.62) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL6105872 | 0.83 | RXFP1 (0.55) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL1826584 | 0.83 | MEN1 (0.46) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL1826585 | 0.83 | MEN1 (0.46) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL4603837 | 0.82 | KDM4E (0.54) | RXFP1KDM4EHSD17B10 | |
| SCHEMBL1827461 | 0.82 | KMT2A (0.50) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL1827641 | 0.82 | KDM4E (0.51) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL1821782 | 0.82 | RXRA (0.59) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL1827463 | 0.82 | KMT2A (0.50) | LIPCLIPGKMT2AMEN1TSHR | |
| SCHEMBL1826814 | 0.81 | MRGPRX4 (0.56) | LIPCLIPGKMT2AMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070066586-A1 | ANILINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1736465-A1 | ANILINE DERIVATIVES | Ajinomoto Co., Inc. (JP) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066586-A1 | ANILINE DERIVATIVES | SERPINB1, ACE, REN | LIPC 2200/4885LIPG 720/4885KMT2A 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.